Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 44,009 shares of NRIX, which is worth approximately $440,970. The most recent transaction as insider was on Jul 20, 2021, when has been sold 1,200 shares (Common Stock) at a price of $1.86 per share, resulting in proceeds of $2,232. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44K
17.93% 3M change
78.96% 12M change
Total Value Held $440,970

Christine Ring Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2021
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 37.44%
2,005 Common Stock
Jun 10 2021
SELL
Open market or private sale
$35,820 $29.85 p/Share
1,200 Reduced 59.85%
805 Common Stock
Jun 10 2021
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 37.44%
2,005 Common Stock
May 10 2021
SELL
Open market or private sale
$32,400 $27.0 p/Share
1,200 Reduced 59.85%
805 Common Stock
May 10 2021
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 37.44%
2,005 Common Stock
Apr 28 2021
SELL
Open market or private sale
$28,200 $35.25 p/Share
800 Reduced 49.84%
805 Common Stock
Apr 28 2021
BUY
Exercise of conversion of derivative security
$1,488 $1.86 p/Share
800 Added 33.26%
1,605 Common Stock
Apr 12 2021
SELL
Open market or private sale
$32,640 $27.2 p/Share
1,200 Reduced 59.85%
805 Common Stock
Apr 12 2021
BUY
Exercise of conversion of derivative security
$2,232 $1.86 p/Share
1,200 Added 37.44%
2,005 Common Stock
Mar 10 2021
SELL
Open market or private sale
$83,680 $41.84 p/Share
2,000 Reduced 71.3%
805 Common Stock
Mar 10 2021
BUY
Exercise of conversion of derivative security
$3,720 $1.86 p/Share
2,000 Added 41.62%
2,805 Common Stock
Feb 18 2021
SELL
Open market or private sale
$71,580 $35.79 p/Share
2,000 Reduced 100.0%
0 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
$3,720 $1.86 p/Share
2,000 Added 50.0%
2,000 Common Stock
CR

Christine Ring

Chief Legal Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX